| Editor's Note | |
| Preface | |
| Law and Practice in France | p. 1 |
| General Features | p. 1 |
| The Different Product Classes and Their Definitions. Underlying Rationale for Separate Legal Treatment | p. 4 |
| Substantive Requirements Relating to the Placing of IVDMDs on the Market | p. 7 |
| The Procedures Relating to the Establishment of the Conformity of IVDMD Business Operations and of IVDMDs Against Operation-Related and/or Product-Related Requirements, Taking Existing Product Classes into Account | p. 12 |
| The Requirements Relating to the Distribution of IVDMDs to the Patient/User, Taking Existing Product Classes into Account | p. 16 |
| Post-Marketing Control: Quality Control Applicable to Laboratories | p. 19 |
| Law and Practice in the Federal Republic of Germany | p. 27 |
| General Features of National Regulation | p. 27 |
| The Different Product Classes and Their Definitions. Underlying Rationale for Separate Legal Treatment | p. 28 |
| Substantive Requirements Relating to the Placing of IVDMDs on the Market | p. 34 |
| The Procedures Relating to the Establishment of the Conformity of IVDMD Business Operations and of IVDMDs Against Operation-Related and/or Product-Related Requirements, Taking Existing Product Classes into Account | p. 47 |
| The Requirements Relating to the Distribution of IVDMDs to the Patient/User, Taking Existing Product Classes into Account | p. 55 |
| Post-Marketing Control: the Requirements Relating to the Control of the Reliability of IVDMDs in View of Their Use | p. 57 |
| Law and Practice in Italy | p. 59 |
| General Features of National Regulation | p. 59 |
| The Different Product Classes and Their Definitions. Underlying Rationale for Separate Legal Treatment | p. 62 |
| Substantive Requirements Relating to the Placing of IVDMDs on the Market | p. 63 |
| The Procedures Relating to the Establishment of the Conformity of IVDMD Business Operations and of IVDMDs Against Operation-Related and/or Product-Related Requirements, Taking Existing Product Classes into Account | p. 68 |
| The Requirements Relating to the Distribution of IVDMDs to the Patient/User, Taking Existing Product Classes into Account | p. 75 |
| Post-Marketing Control: the Requirements Relating to the Control of the Reliability of IVDMDs in View of Their Use | p. 77 |
| Law and Practice in Spain | p. 78 |
| General Features of National Regulation | p. 78 |
| The Different Product Classes and Their Definitions. Underlying Rationale for Separate Legal Treatment | p. 80 |
| Substantive Requirements Relating to the Placing of IVDMDs on the Market | p. 80 |
| Procedures Relating to the Establishment of the Conformity of IVDMD Business Operations and of IVDMDs Against Operation-Related and/or Product-Related Requirements | p. 81 |
| Requirements Relating to the Distribution of IVDMDs to the Patient/User | p. 82 |
| Post-Marketing Control | p. 82 |
| Law and Practice in The United Kingdom | p. 84 |
| General Features of National Regulation | p. 84 |
| Different Product Classes | p. 85 |
| Substantive Requirements Relating to the Placing of IVDMDs on the Market | p. 86 |
| Procedures Relating to the Establishment of the Conformity of IVDMD Business Operations and of IVDMDs against Operation-Related and/or Product-Related Requirements | p. 100 |
| Requirements Relating to the Distribution of IVDMDs to the Patient/User | p. 101 |
| Post-Marketing Control | p. 103 |
| Summary of Findings of the National Reports | p. 105 |
| General Overview | p. 105 |
| The Different Product Classes and Their Definitions. Underlying Rationale for Separate Legal Treatment | p. 107 |
| Substantive Requirements Relating to the Placing of IVDMDs on the Market | p. 108 |
| Procedures Relating to the Establishment of the Conformity of IVDMD Business Operations and of IVDMDs Against Operation-Related and/or Product-Related Requirements, Taking Existing Product Classes into Account | p. 113 |
| Requirements Relating to the Distribution of IVDMDs to the Patient/User, Taking Existing Product Classes into Account | p. 115 |
| Post-Marketing Control: Requirements Relating to Control of Reliability of IVDMDs in View of Their Use | p. 116 |
| Table of Contents provided by Blackwell. All Rights Reserved. |